<DOC>
	<DOCNO>NCT00930306</DOCNO>
	<brief_summary>The aim study examine effect repeat dos AZD2066 caffeine , bupropion , tolbutamide , omeprazole , metoprolol midazolam blood concentration</brief_summary>
	<brief_title>AZD2066 Cocktail Study</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Tolbutamide</mesh_term>
	<criteria>Provision inform consent prior studyspecific procedure Healthy volunteer BMI 18 30 kg/m2 Medical surgical history physical examination without clinically significant finding Non smoker past smoker stop smoke within last 6 month . History previous ongoing psychiatric disease/condition include psychosis , affective disorder , anxiety disorder , personality disorder significant psychiatric disorder major disorder may interfere objective study , judge Investigator Clinically significant illness judge Investigator , within four week first administration investigational product . Female subject positive pregnancy test pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>AZD2066</keyword>
</DOC>